U.S. Federal Issues

Access to Therapies

PPTA works with Congress and various agencies within the United States Department of Health and Human Services in communicating the importance of unfettered consumer access to all plasma-derived and recombinant analog therapies (collectively "plasma protein therapies") while at the same time educating policymakers on the unique, niche biologics industry that produces these lifesaving medicines.

PPTA in unison with its stakeholders advocates on patient access to care, which is at the forefront of the Association's agenda.

Medicare Coverage of Plasma Protein Therapies
Administrative Initiatives: • PPTA Comment Letter to CMS on the CY 2008 Hospital Outpatient Prospective Payment System Proposed Rule September, 01, 2007; • PPTA Comment Letter to CMS on its Porposal for the 2009 Healthcare Common Procedure Coding Systems Codes Application September, 01, 2007; • PPTA Comment Letter to CMS on the CY 2008 Physician Fee Schedule Proposed Rule August, 01, 2007

PPTA Headquarters
147 Old Solomons Island Road
Suite 100
Annapolis, MD 21401
Phone: +1.202.789.3100
Fax: +1.410.263.2298

Europe Office
Boulevard Brand Whitlock 114/5
1200 Brussels, Belgium
Phone:+32.(0)2.705.5811
Fax: +32.(0)2.705.5820

Japan Office
Yebisu Garden Place Tower 18F
4-20-3 Ebisu, Shibuyu-ku
Tokyo 150-6018 Japan
Phone: +81.3.5789.5925
Fax: +81.3.5789.5757